Area of research
Physiology · Psychiatry and Mental health
Research interest
ECU | Professor Ralph Martins AO : Researchers : Centre of Excellence for Alzheimer's Disease Research and Care : Neuroscience and Neurorehabilitation : School research areas : Our research : Medical and Health Sciences : Schools.
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease
The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset
Development and validation of the Montreal Cognitive Assessment for People with Vision Impairment (MOCA-VI).
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression
Progression of cerebral amyloid angiopathy: a pathophysiological framework
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease
Multi-Domain Interventions for Dementia Prevention–A Systematic Review
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans
Immune-mediated hematological disease in dogs is associated with alterations of the fecal microbiota: a pilot study
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition
Autosomal dominant and sporadic late onset Alzheimer's disease share a common<i>in vivo</i>pathophysiology
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
Structural core of the executive control network: A high angular resolution diffusion MRI study
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need